SOPHiA GENETICS (SOPH) Short Interest Ratio & Short Volume $3.16 -0.05 (-1.41%) Closing price 08/8/2025 03:58 PM EasternExtended Trading$3.14 -0.01 (-0.32%) As of 08/8/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SOPHiA GENETICS Short Interest DataSOPHiA GENETICS (SOPH) has a short interest of 35,800 shares, representing 0.07% of the float (the number of shares available for trading by the public). This marks a 123.75% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 81,476 shares to cover all short positions.Current Short Interest35,800 sharesPrevious Short Interest16,000 sharesChange Vs. Previous Month+123.75%Dollar Volume Sold Short$124.23 thousandShort Interest Ratio0.5 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares67,580,000 sharesFloat Size51,780,000 sharesShort Percent of Float0.07%Today's Trading Volume24,088 sharesAverage Trading Volume81,476 sharesToday's Volume Vs. Average30% Short Selling SOPHiA GENETICS? Sign up to receive the latest short interest report for SOPHiA GENETICS and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSOPH Short Interest Over TimeSOPH Days to Cover Over TimeSOPH Percentage of Float Shorted Over Time SOPHiA GENETICS Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202535,800 shares $124.23 thousand +123.8%0.1%0.5 $3.47 6/30/202516,000 shares $49.60 thousand -16.2%0.0%0.2 $3.10 6/15/202519,100 shares $54.82 thousand -37.8%0.0%0.3 $2.87 5/31/202530,700 shares $91.49 thousand +8.1%0.1%1 $2.98 5/15/202528,400 shares $88.32 thousand -34.1%0.1%0.8 $3.11 4/30/202543,100 shares $131.46 thousand -8.7%0.1%0.8 $3.05 4/15/202547,200 shares $132.63 thousand -6.5%0.1%0.7 $2.81 3/31/202550,500 shares $167.66 thousand +4.1%0.1%0.6 $3.32 3/15/202548,500 shares $156.17 thousand -21.5%0.1%0.6 $3.22 2/28/202561,800 shares $226.81 thousand +64.4%0.1%0.8 $3.67 Get the Latest News and Ratings for SOPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SOPHiA GENETICS and its competitors with MarketBeat's FREE daily newsletter. 2/15/202537,600 shares $150.78 thousand +89.9%0.1%0.5 $4.01 1/31/202519,800 shares $69.30 thousand -34.0%0.0%0.4 $3.50 1/15/202530,000 shares $95.40 thousand -4.5%0.1%0.7 $3.18 12/31/202431,400 shares $96.40 thousand -15.1%0.1%1.2 $3.07 12/15/202437,000 shares $121.36 thousand +38.6%0.1%1.5 $3.28 11/30/202426,700 shares $91.05 thousand -52.7%0.1%1 $3.41 11/15/202456,500 shares $199.45 thousand +134.4%0.1%1.9 $3.53 10/31/202424,100 shares $86.28 thousand +66.2%0.1%0.6 $3.58 10/15/202414,500 shares $50.17 thousand -0.7%0.0%0.3 $3.46 9/30/202414,600 shares $53.29 thousand -22.8%0.0%0.3 $3.65 9/15/202418,900 shares $75.79 thousand -52.0%0.0%0.3 $4.01 8/31/202439,400 shares $151.30 thousand +47.0%0.1%0.5 $3.84 8/15/202426,800 shares $89.51 thousand -61.6%0.1%0.2 $3.34 7/31/202469,800 shares $307.12 thousand -12.4%0.2%0.7 $4.40 7/15/202479,700 shares $366.62 thousand -12.6%0.2%0.8 $4.60 6/30/202491,200 shares $417.70 thousand +22.3%0.2%0.8 $4.58 6/15/202474,600 shares $360.32 thousand +38.2%0.2%0.7 $4.83 5/31/202454,000 shares $269.46 thousand +155.9%0.1%0.5 $4.99 5/15/202421,100 shares $97.90 thousand -57.7%0.1%0.3 $4.64 4/30/202449,900 shares $254.49 thousand +7.8%0.1%0.8 $5.10 4/15/202446,300 shares $225.02 thousand -12.0%0.1%0.8 $4.86 3/31/202452,600 shares $259.32 thousand +22.3%0.1%1 $4.93 3/15/202443,000 shares $191.78 thousand -28.6%0.1%0.9 $4.46 2/29/202460,200 shares $301 thousand -0.7%0.1%1.3 $5.00 2/15/202460,600 shares $285.43 thousand -2.4%0.1%1.7 $4.71 1/31/202462,100 shares $285.04 thousand +7.4%0.1%1.7 $4.59 1/15/202457,800 shares $302.29 thousand +19.2%0.1%1.3 $5.23 12/31/202348,500 shares $228.44 thousand -4.9%0.1%1.2 $4.71 12/15/202351,000 shares $223.38 thousand +50.4%0.1%1.5 $4.38 11/30/202333,900 shares $136.28 thousand +52.7%0.1%1.1 $4.02Buffett’s $325 Billion Cash Problem — Solved by Gold? (Ad)A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.Discover how you could front-run Buffett’s gold move with Garrett’s Top Four picks. 11/15/202322,200 shares $86.80 thousand -51.7%0.1%0.6 $3.91 10/31/202346,000 shares $169.74 thousand +59.2%0.1%1 $3.69 10/15/202328,900 shares $89.88 thousand -20.2%0.1%0.6 $3.11 9/30/202336,200 shares $92.13 thousand +35.6%0.1%0.7 $2.55 9/15/202326,700 shares $64.35 thousand -4.3%0.1%0.5 $2.41 8/31/202327,900 shares $68.08 thousand +1.1%0.1%0.5 $2.44 8/15/202327,600 shares $80.04 thousand +22.1%0.1%0.5 $2.90 7/31/202322,600 shares $85.88 thousand -27.6%0.1%0.3 $3.80 7/15/202331,200 shares $142.90 thousand -12.9%0.1%0.5 $4.58 6/30/202335,800 shares $160.38 thousand -23.2%0.1%0.6 $4.48 6/15/202346,600 shares $192.46 thousand -7.5%0.1%0.7 $4.13 5/31/202350,400 shares $234.86 thousand -44.6%0.1%0.4 $4.66 5/15/202390,900 shares $405.41 thousand -15.6%0.2%0.7 $4.46 4/30/2023107,700 shares $521.27 thousand +5.1%0.2%1 $4.84 4/15/2023102,500 shares $447.93 thousand -11.6%0.2%0.8 $4.37 3/31/2023116,000 shares $576.52 thousand -74.2%0.3%0.9 $4.97 3/15/2023449,700 shares $2.19 million +1,207.3%1.0%3.5 $4.86 2/28/202334,400 shares $89.44 thousand -17.7%0.1%0.4 $2.60 2/15/202341,800 shares $112.02 thousand +7.5%0.1%0.6 $2.68 1/31/202338,900 shares $116.70 thousand -31.5%0.1%0.5 $3.00 1/15/202356,800 shares $177.78 thousand +3.5%0.1%0.6 $3.13 12/30/202254,900 shares $113.09 thousand +43.7%0.1%0.7 $2.06 12/15/202238,200 shares $89.01 thousand -34.5%0.1%0.5 $2.33 11/30/202258,300 shares $134.67 thousand -3.0%0.1%0.6 $2.31 11/15/202260,100 shares $123.21 thousand +4.0%0.1%0.6 $2.05 10/31/202257,800 shares $127.16 thousand -25.3%0.1%0.6 $2.20 10/15/202277,400 shares $175.70 thousand -18.2%0.2%0.8 $2.27 9/30/202294,600 shares $248.80 thousand No Change0.2%1.1 $2.63 9/15/202294,600 shares $255.42 thousand -32.1%0.2%1.1 $2.70 8/31/2022139,300 shares $458.30 thousand +10.3%0.3%1.5 $3.29 8/15/2022126,300 shares $568.35 thousand -23.8%0.3%1.4 $4.50 7/31/2022165,800 shares $572.01 thousand -2.9%0.3%1.7 $3.45 7/15/2022170,700 shares $529.17 thousand -6.6%0.4%1.7 $3.10 6/30/2022182,800 shares $661.74 thousand -50.3%0.4%1.8 $3.62 6/15/2022367,600 shares $1.03 million -27.8%0.8%3.5 $2.80 5/31/2022509,000 shares $2.14 million -0.9%1.1%6 $4.20 5/15/2022513,500 shares $2.47 million -3.9%1.1%7.4 $4.81 4/30/2022534,100 shares $3.43 million -3.2%1.1%8.3 $6.43 4/15/2022552,000 shares $3.86 million -8.0%1.1%7.1 $7.00 3/31/2022600,000 shares $4.64 million -16.1%1.2%6.6 $7.73 3/15/2022715,300 shares $5.87 million -1.1%1.4%8.4 $8.21 2/28/2022723,000 shares $9.25 million +7.3%1.4%8.8 $12.80 2/15/2022673,900 shares $8.21 million -18.2%1.3%7.7 $12.18 1/31/2022823,900 shares $9.64 million +41.3%1.6%8.9 $11.70 1/15/2022582,900 shares $8.24 million +6.9%1.2%6.8 $14.13 12/31/2021545,400 shares $7.69 million +6.3%1.1%8.9 $14.10 12/15/2021512,900 shares $6.94 million -6.8%1.0%8.7 $13.54 11/30/2021550,400 shares $7.69 million +17.2%1.1%9.7 $13.98 11/15/2021469,700 shares $7.42 million +3.8%0.9%8.1 $15.80 10/29/2021452,600 shares $6.42 million -1.3%0.9%6.9 $14.19Buffett’s $325 Billion Cash Problem — Solved by Gold? (Ad)A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.Discover how you could front-run Buffett’s gold move with Garrett’s Top Four picks. 10/15/2021458,600 shares $7.38 million +0.6%0.9%4.5 $16.10 9/30/2021456,000 shares $7.99 million +2.7%0.9%2.8 $17.53 9/15/2021444,000 shares $7.21 million -0.3%0.9%2.3 $16.23 8/31/2021445,400 shares $8.81 million +85.1%0.9%1.9 $19.77 8/13/2021240,600 shares $4.33 million No Change0.5%0.7 $18.00 SOPH Short Interest - Frequently Asked Questions What is SOPHiA GENETICS's current short interest? Short interest is the volume of SOPHiA GENETICS shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 35,800 shares of SOPH short. 0.07% of SOPHiA GENETICS's shares are currently sold short. Learn More on SOPHiA GENETICS's current short interest. What is a good short interest percentage for SOPHiA GENETICS? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.07% of SOPHiA GENETICS's floating shares are currently sold short. Is SOPHiA GENETICS's short interest increasing or decreasing? SOPHiA GENETICS saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 35,800 shares, an increase of 123.8% from the previous total of 16,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is SOPHiA GENETICS's float size? SOPHiA GENETICS currently has issued a total of 67,580,000 shares. Some of SOPHiA GENETICS's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. SOPHiA GENETICS currently has a public float of 51,780,000 shares. How does SOPHiA GENETICS's short interest compare to its competitors? 0.07% of SOPHiA GENETICS's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to SOPHiA GENETICS: Immunome, Inc. (18.49%), Nurix Therapeutics, Inc. (18.25%), LENZ Therapeutics, Inc. (16.99%), Mineralys Therapeutics, Inc. (19.37%), Trevi Therapeutics, Inc. (8.48%), Syndax Pharmaceuticals, Inc. (27.50%), Oric Pharmaceuticals, Inc. (14.42%), Urogen Pharma (15.76%), Nuvation Bio Inc. (31.53%), ProKidney Corp. (11.75%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short SOPHiA GENETICS stock? Short selling SOPH is an investing strategy that aims to generate trading profit from SOPHiA GENETICS as its price is falling. SOPH shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against SOPHiA GENETICS? A short squeeze for SOPHiA GENETICS occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SOPH, which in turn drives the price of the stock up even further. How often is SOPHiA GENETICS's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SOPH, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies IMNM Short Interest Data NRIX Short Interest Data LENZ Short Interest Data MLYS Short Interest Data TRVI Short Interest Data SNDX Short Interest Data ORIC Short Interest Data URGN Short Interest Data NUVB Short Interest Data PROK Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SOPH) was last updated on 8/10/2025 by MarketBeat.com Staff From Our Partners#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SOPHiA GENETICS SA Please log in to your account or sign up in order to add this asset to your watchlist. Share SOPHiA GENETICS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SOPH Stock Alerts